Advertisement

Topics

Cancer Drug Manufacturer Settles Three-year Court Battle Over Alleged FCA Violations

20:00 EDT 16 Aug 2017 | AHC Media

The Department of Justice announced that the pharmaceutical manufacturer Celgene has agreed to pay $280 million to settle allegations that the company fraudulently promoted two cancer treatment drugs for uses not approved by the FDA.

Original Article: Cancer Drug Manufacturer Settles Three-year Court Battle Over Alleged FCA Violations

NEXT ARTICLE

More From BioPortfolio on "Cancer Drug Manufacturer Settles Three-year Court Battle Over Alleged FCA Violations"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...